Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# AMD Soars: Analyst Boosts Price Target! **Overview:** Advanced Micro Devices (AMD) has seen its stock price surge on the back of strong financial results and optimism about its…
Read more# PBT Surges: Unlocking New Royalty Opportunities!
Read more# APP: Big Moves Yesterday—Don't Miss Out!
Read more# TER: Shares Soaring Today—Don't Miss Out! ## Company Overview and Recent Surge Teradyne, Inc. (NASDAQ: **TER**) is a leading supplier of automated test equipment for…
Read more# DLR: Unlocking Growth with New Data Center Expansion! ## Overview – Expansion-Driven Growth **Digital Realty Trust (NYSE: DLR)** is a leading global data center REIT that is…
Read more# CBRS Soars 19% on Stellar Q1 Results! Don’t Miss Out! ## Company Overview Cerebras Systems (NASDAQ: **CBRS**) is a cutting-edge semiconductor company specializing in **AI…
Read more# MAMA's $100M Offering: Big Moves Ahead! ## Company Overview and Recent Offering **Mama’s Creations, Inc.
Read more# EMBC: Join the Fight Against Securities Fraud!
Read more# DDOG Surges Today—Don't Miss Out on Gains! ## Introduction Datadog, Inc. (NASDAQ: DDOG) is a cloud-native monitoring and analytics platform for infrastructure, applications, and…
Read more# PFS Soars: AbbVie’s Phase 3 Results Ignite Hope!
Read more# Introduction While breakthrough Alzheimer’s treatments by companies like Eisai grab headlines, investors might overlook a different “AD” – **Koninklijke Ahold Delhaize N.V.…
Read more# SEI Surges: Discover Today’s Key Catalyst! **Overview:** Solaris Energy Infrastructure, Inc. (NYSE: SEI) – formerly Solaris Oilfield Infrastructure – has seen its stock surge to…
Read more# GILD’s Trodelvy Approval: A Game Changer for Oncology! ## Introduction Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company historically known for its antiviral…
Read more# DCOY: $21M Financing Sparks Growth Potential! ## Company Overview & Latest Financing Decoy Therapeutics, Inc.
Read more# LRCX Soars: Barclays Maintains “Overweight” Rating! ## Recent Performance & Barclays’ Stance Lam Research Corporation (NASDAQ: **LRCX**) – a leading supplier of semiconductor…
Read more# EMBC: Urgent! Secure Counsel Before Class Action Deadline! **Embecta Corp.
Read more# C: Nektar’s Inducement Grants Could Boost Citigroup! **Introduction:** Nektar Therapeutics’ recent move to attract talent with inducement stock grants might seem unrelated to…
Read more# AU’s $2B Buyback: A Game Changer for Capital Strategy? ## Introduction AngloGold Ashanti (NYSE: AU) has stunned the market by announcing a **$2 billion share buyback program**,…
Read more# LLY Soars: Positive Phase 3 Results for Jaypirca!
Read more# Is Micron Stock the Next NVDA? Find Out Now!
Read more
